Literature DB >> 9167468

BCG vaccine in insulin-dependent diabetes mellitus. IMDIAB Group.

P Pozzilli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9167468     DOI: 10.1016/s0140-6736(05)62100-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  In vivo imaging of insulitis in autoimmune diabetes.

Authors:  A Signore; M Chianelli; M G Parisella; G Capriotti; P Giacalone; G Di Leve; R Barone
Journal:  J Endocrinol Invest       Date:  1999-02       Impact factor: 4.256

Review 2.  Immunisation and type 1 diabetes mellitus: is there a link?

Authors:  M Hiltunen; M Lönnrot; H Hyöty
Journal:  Drug Saf       Date:  1999-03       Impact factor: 5.606

3.  Infection in systemic lupus erythematosus: friend or foe?

Authors:  Lisa Francis; Andras Perl
Journal:  Int J Clin Rheumtol       Date:  2010-02-01

4.  Superior Cervical Sympathetic Ganglion: Normal Imaging Appearance on 3T-MRI.

Authors:  Joo Yeon Lee; Jeong Hyun Lee; Joon Seon Song; Min Jeong Song; Seung-Jun Hwang; Ra Gyoung Yoon; Seung Won Jang; Ji Eun Park; Young Jin Heo; Young Jun Choi; Jung Hwan Baek
Journal:  Korean J Radiol       Date:  2016-08-23       Impact factor: 3.500

5.  Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations.

Authors:  Willem M Kühtreiber; Lisa Tran; Taesoo Kim; Michael Dybala; Brian Nguyen; Sara Plager; Daniel Huang; Sophie Janes; Audrey Defusco; Danielle Baum; Hui Zheng; Denise L Faustman
Journal:  NPJ Vaccines       Date:  2018-06-21       Impact factor: 7.344

6.  Therapeutic Effects of BCG Vaccination on Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Yu-Chen Chang; Chien-Ju Lin; Yu-Hsuan Hsiao; Yu-Han Chang; Shu-Jung Liu; Hsin-Yin Hsu
Journal:  J Diabetes Res       Date:  2020-03-26       Impact factor: 4.011

7.  Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes.

Authors:  Denise L Faustman; Limei Wang; Yoshiaki Okubo; Douglas Burger; Liqin Ban; Guotong Man; Hui Zheng; David Schoenfeld; Richard Pompei; Joseph Avruch; David M Nathan
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

Review 8.  BCG turns 100: its nontraditional uses against viruses, cancer, and immunologic diseases.

Authors:  Alok K Singh; Mihai G Netea; William R Bishai
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 19.456

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.